152 related articles for article (PubMed ID: 19375269)
1. Evaluation of ischemia-modified albumin in myocardial infarction and prostatic diseases.
Mastella AK; Moresco RN; da Silva DB; Becker AM; Duarte MM; Giovelli LL; da Silva SH; Rossato L; Moretto MB; da Silva JE
Biomed Pharmacother; 2009 Dec; 63(10):762-6. PubMed ID: 19375269
[TBL] [Abstract][Full Text] [Related]
2. Association between ischemia-modified albumin, lipids and inflammation biomarkers in patients with hypercholesterolemia.
Duarte MM; Rocha JB; Moresco RN; Duarte T; Da Cruz IB; Loro VL; Schetinger MR
Clin Biochem; 2009 May; 42(7-8):666-71. PubMed ID: 19318029
[TBL] [Abstract][Full Text] [Related]
3. Ischemia Modified Albumin for the assessment of patients presenting to the emergency department with acute chest pain but normal or non-diagnostic 12-lead electrocardiograms and negative cardiac troponin T.
Roy D; Quiles J; Aldama G; Sinha M; Avanzas P; Arroyo-Espliguero R; Gaze D; Collinson P; Carlos Kaski J
Int J Cardiol; 2004 Nov; 97(2):297-301. PubMed ID: 15458698
[TBL] [Abstract][Full Text] [Related]
4. Serum ischaemia-modified albumin increases in critical lower limb ischaemia.
Gunduz A; Mentese A; Turedi S; Karahan SC; Mentese U; Eroglu O; Turkmen S; Turan I; Ucar U; Russell R; Balaban F
Emerg Med J; 2008 Jun; 25(6):351-3. PubMed ID: 18499817
[TBL] [Abstract][Full Text] [Related]
5. Effect of deep vein thrombosis on ischaemia-modified albumin levels.
Mentese A; Mentese U; Turedi S; Gunduz A; Karahan SC; Topbas M; Turan A; Patan T; Turkmen S; Okur G; Eminagaoglu MS
Emerg Med J; 2008 Dec; 25(12):811-4. PubMed ID: 19033496
[TBL] [Abstract][Full Text] [Related]
6. Ischemia-modified albumin levels in cerebrovascular accidents.
Gunduz A; Turedi S; Mentese A; Altunayoglu V; Turan I; Karahan SC; Topbas M; Aydin M; Eraydin I; Akcan B
Am J Emerg Med; 2008 Oct; 26(8):874-8. PubMed ID: 18926343
[TBL] [Abstract][Full Text] [Related]
7. Value of ischemia-modified albumin in the diagnosis of pulmonary embolism.
Turedi S; Gunduz A; Mentese A; Karahan SC; Yilmaz SE; Eroglu O; Nuhoglu I; Turan I; Topbas M
Am J Emerg Med; 2007 Sep; 25(7):770-3. PubMed ID: 17870479
[TBL] [Abstract][Full Text] [Related]
8. Investigation of the possibility of using ischemia-modified albumin as a novel and early prognostic marker in cardiac arrest patients after cardiopulmonary resuscitation.
Turedi S; Gunduz A; Mentese A; Dasdibi B; Karahan SC; Sahin A; Tuten G; Kopuz M; Alver A
Resuscitation; 2009 Sep; 80(9):994-9. PubMed ID: 19581040
[TBL] [Abstract][Full Text] [Related]
9. Relation of ischemia-modified albumin levels and left ventricular systolic function in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
Dominguez-Rodriguez A; Abreu-Gonzalez P; Garcia-Gonzalez MJ; Samimi-Fard S; Kaski JC
Clin Chim Acta; 2008 Feb; 388(1-2):196-9. PubMed ID: 18036561
[TBL] [Abstract][Full Text] [Related]
10. [Diagnostic value of ischemia-modified albumin in patients with acute coronary syndrome].
Shen XL; Xing C; Han LL; Lin L; Lin LF; Deng YL; Pu XD; Hu XZ
Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Sep; 35(9):814-7. PubMed ID: 18070473
[TBL] [Abstract][Full Text] [Related]
11. Effect of temperature on albumin cobalt binding and its influence on ischemia-modified albumin levels in patients with suspected acute coronary syndrome.
Hausen BS; Signor C; Kober H; Tatsch E; Pereira RS; Duarte T; Hermes CL; Duarte MM; Moresco RN
Clin Lab; 2012; 58(1-2):169-72. PubMed ID: 22372361
[TBL] [Abstract][Full Text] [Related]
12. Ischemia-modified albumin levels predict long-term outcome in patients with acute myocardial infarction. The French Nationwide OPERA study.
Van Belle E; Dallongeville J; Vicaut E; Degrandsart A; Baulac C; Montalescot G;
Am Heart J; 2010 Apr; 159(4):570-6. PubMed ID: 20362714
[TBL] [Abstract][Full Text] [Related]
13. Application of albumin-adjusted ischemia modified albumin index as an early screening marker for acute coronary syndrome.
Lee YW; Kim HJ; Cho YH; Shin HB; Choi TY; Lee YK
Clin Chim Acta; 2007 Sep; 384(1-2):24-7. PubMed ID: 17570353
[TBL] [Abstract][Full Text] [Related]
14. Characteristics of a nickel-albumin binding assay for assessment of myocardial ischaemia.
da Silva SH; Hausen Bdos S; da Silva DB; Becker AM; de Campos MM; Duarte MM; Moresco RN
Biomarkers; 2010 Jun; 15(4):353-7. PubMed ID: 20384453
[TBL] [Abstract][Full Text] [Related]
15. Ischemia modified albumin, a marker of acute ischemic events: a pilot study.
Talwalkar SS; Bon Homme M; Miller JJ; Elin RJ
Ann Clin Lab Sci; 2008; 38(2):132-7. PubMed ID: 18469358
[TBL] [Abstract][Full Text] [Related]
16. Ischemia modified albumin is a sensitive marker of myocardial ischemia after percutaneous coronary intervention.
Sinha MK; Gaze DC; Tippins JR; Collinson PO; Kaski JC
Circulation; 2003 May; 107(19):2403-5. PubMed ID: 12742986
[TBL] [Abstract][Full Text] [Related]
17. Prediction of myocardial infarction by N-terminal-pro-B-type natriuretic peptide, C-reactive protein, and renin in subjects with cerebrovascular disease.
Campbell DJ; Woodward M; Chalmers JP; Colman SA; Jenkins AJ; Kemp BE; Neal BC; Patel A; MacMahon SW
Circulation; 2005 Jul; 112(1):110-6. PubMed ID: 15983245
[TBL] [Abstract][Full Text] [Related]
18. [Ischemia modified albumin--specific marker in cardiological diagnostics?].
Knapik-Kordecka M; Piwowar A; Zurawska-Płaksej E; Warwas M
Wiad Lek; 2008; 61(10-12):263-8. PubMed ID: 19323066
[TBL] [Abstract][Full Text] [Related]
19. Ischemia-modified albumin: is it a reliable diagnostic and prognostic marker for myocardial ischemia in real clinical practice?
Kim JS; Hwang HJ; Ko YG; Kim JS; Choi D; Ha JW; Hong MK; Jang Y
Cardiology; 2010; 116(2):123-9. PubMed ID: 20588021
[TBL] [Abstract][Full Text] [Related]
20. Calculated fast-growing benign prostatic hyperplasia--a risk factor for developing clinical prostate cancer.
Hammarsten J; Högstedt B
Scand J Urol Nephrol; 2002; 36(5):330-8. PubMed ID: 12487736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
